Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC): Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Andreas Jay Kind, Dominik Paul Modest, Christine Sers, Soulafa Mamlouk, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Ludwig Fischer Von Weikersthal, Eray Goekkurt, Anke C. Reinacher-Schick, Stefan Kasper, Annika Kurreck, Beeke Hoppe, Swantje Held, Volker Heinemann, David Horst, Armin Jarosch, Sebastian Stintzing, Tanja Trarbach, Arndt Stahler
Institutions: Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité – Universitätsmedizin Berlin, München Klinik Harlaching, München Klinik Neuperlach, Klinik Dr. Hancken, Kliniken Maria Hilf, Klinikum St. Marien Amberg, St. Josef-Hospital, Ruhr University Bochum, Essen University Hospital, ClinAssess (Germany), Ludwig-Maximilians-Universität München
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281812475